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in placement at the inframalleolar position because of
space constraints. Therefore, we embarked on the use of
PTFE grafts with a distal vein patch (DVP) to enhance the
patency of tibial bypass grafts in limb-threatened patients
without available autogenous vein. This series describes
the long-term results of PTFE/DVP bypass grafts to tib-
ial arteries for limb salvage.
METHODS
A total of 514 tibial artery bypass grafts were per-
formed for limb salvage from July 1993 to July 1999.
Included in this patient cohort were 80 bypass grafts per-
formed in 79 patients with PTFE/DVP as the graft con-
duit. The PTFE/DVP group represented 16% of the total
tibial bypass graft experience during this time period. For
the purposes of this report, the charts of the patients with
a PTFE/DVP bypass graft were reviewed. Patient status
was updated through direct contact with the patient or the
family in each case.
All patients were evaluated preoperatively with contrast
arteriography to plan the appropriate revascularization. An
attempt was made to locate saphenous vein (ipsilateral or
contralateral) through careful physical examination supple-
mented with duplex ultrasound evaluation. If the vein was
of questionable quality, then it was evaluated under direct
vision at operation. In each patient who received a
PTFE/DVP bypass graft, the ipsilateral and the contralat-
eral greater saphenous vein either was unavailable, having
been used for previous revascularization procedures, or was
unsuitable because of inadequate length or quality.
The bypass grafts were performed with patients under
epidural anesthesia in most cases with selective use of Swan-
There is little question that saphenous vein is the con-
duit of choice for tibial bypass grafting. However, there
seems to be an increasing number of patients in need of
tibial bypass graft for limb salvage who do not have ade-
quate saphenous vein available. Several alternative con-
duits have been proposed, including lesser saphenous vein,
arm vein, composite veins, composite vein with polytetra-
fluoroethylene (PTFE), and PTFE with or without a dis-
tal arteriovenous fistula. Unfortunately, these alternative
conduits have not resulted in equivalent results when used
for distal bypass graft to tibial arteries.1-4 This has led
some to advocate primary amputation with no attempt at
limb salvage in certain patient subgroups.5 Conversely,
several authors have reported on the use of venous tissue
at the distal anastomosis in the form of cuffs, collars, and
boots to improve the results of prosthetic grafts to tibial
arteries.6-8 These techniques have been proposed as an
option for revascularization in patients without adequate
saphenous vein in an attempt to obtain limb salvage.
Having tried several of the venous cuffs and collars, we
found the procedures somewhat complex involving multi-
ple intricate suture lines. In addition, there was difficulty
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Tibial bypass for limb salvage using
polytetrafluoroethylene and a distal vein patch
Richard F. Neville, MD, Barbara Tempesta, NP, and Anton N. Sidawy, MD, Washington, DC
Objective: Tibial artery bypass for limb salvage may be required in patients without adequate autogenous vein. The
interposition of venous tissue at the distal anastomosis has been advocated to improve the results of prosthetic grafts
to tibial arteries. Having reported on technical feasibility and an early experience with polytetrafluoroethylene (PTFE)
and a distal vein patch (DVP), we examine the results of this technique with 4-year follow-up.
Methods: From July 1993 to July 1999, 514 tibial bypass grafts were performed, with 80 bypass grafts in 79 patients
with PTFE/DVP as the conduit. Patient demographics included 39 men and 40 women (mean age, 67 years); 42 had
diabetes mellitus (53%), 16 had renal failure (20%), and 48 had Eagle criteria for increased cardiac risk (60%).
Indications for revascularization were rest pain in 39 (49%) and tissue loss in 41 (51%). Lack of adequate vein resulted
from previous failed lower extremity bypass graft (47 [59%]), previous coronary bypass graft (21 [26%]), unsuitable
vein (8 [10%]), and absent vein due to ligation and stripping (4 [5%]). Follow-up ranged from 1 to 48 months. Results
are reported as primary patency or limb salvage ± SE.
Results: Bypass grafts originated from the common femoral artery (40 [50%]), the superficial femoral artery (6 [8%]), and
the external iliac artery (34 [43%]). Recipient arteries included anterior tibial (17 [21%]), posterior tibial (28 [35%]), and
peroneal (35 [44%]). Four-year primary patency and limb salvage rates were 62.89% ± 10.6% and 79.21% ± 8.45%, respec-
tively. There was a 24% mortality rate during the follow-up period. Acute failure occurred in 7 grafts with 5 immediate
amputations and 2 revisions. A total of 17 grafts failed during the follow-up period, leading to 11 amputations.
Conclusion: The DVP technique allows PTFE bypass grafts to tibial arteries with acceptable long-term patency and limb
salvage. (J Vasc Surg 2001;33:266-72.)
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Ganz catheterization. The artery chosen as the inflow site
was exposed in standard fashion. A retroperitoneal
approach to the external iliac artery was used in several cases
because of multiple previous groin procedures with subse-
quent scar formation. Distal exposure varied according to
the tibial artery chosen for bypass graft. After proximal and
distal arterial exposure, a 2- to 3-cm segment of vein was
harvested from any available location. Vein for the patch
included saphenous remnants, arm vein harvested with
patients under local anesthesia, and, rarely, superficial
femoral vein. This vein segment was gently irrigated with
prepared vein solution and opened longitudinally. The vein
solution was composed of buffered saline solution (Plasma-
Lyte-A) (1000 mL, pH 7.4), heparin (5000 units), calcium
chloride (10%, 100 mg), and papaverine (120 mg). Any
valves were excised, and the vein segment was briefly stored
in the vein solution. An externally reinforced, 6-mm, thin-
walled PTFE graft was then tunneled between the proximal
and distal arterial dissections. The tunnel was routed medi-
ally; however, when a bypass graft to the anterior tibial
artery was planned, the tunnel was made laterally. In addi-
tion, if a distal peroneal artery was targeted via a lateral
approach with segmental fibulectomy, a lateral tunnel was
also used. Heparin was given, and an end-to-side proximal
anastomosis was performed between the PTFE graft and
the inflow artery with a standard continuous suturing tech-
nique. A 2- to 3-cm arteriotomy was then performed in the
artery chosen for distal anastomosis. The venous segment
was cut to the appropriate length and width in preparation
for the patch. In most cases, the width was left unaltered to
allow for a generous patch to permit bulging of the patch
under arterial flow somewhat like a cuff. Rarely, the vein
width was trimmed to allow for a better size match with a
small tibial artery. The vein patch was sutured to the artery
with 7-0 Prolene suture by means of standard parachute
techniques. The PTFE/DVP anastomosis was then per-
formed as previously described.9 A longitudinal venotomy
was then made in the proximal two thirds of the patch. The
venotomy was positioned to begin the heel of the
PTFE/vein anastomosis just beyond the artery/vein patch
suture line. The PTFE graft was cut to the appropriate
length in a sigmoidal fashion to allow the sides to flare in a
“cobra-head” configuration. The PTFE graft was then
sutured to the vein patch with 6-0 Prolene suture in a con-
tinuous fashion allowing a rim of venous tissue interposed
between the PTFE graft and the arterial wall. More venous
tissue was left interposed at the toe of the anastomosis than
the heel (Fig 1). Completion arteriography was performed
in each case (Fig 2).
Patients were transferred to the intensive care or step-
down unit on the basis of their medical condition. A
heparin infusion was started 4 to 6 hours postoperatively
with Coumadin administered on the first postoperative
day. Long-term anticoagulation with Coumadin was con-
tinued with an international normalized ratio of 2.0 as the
goal. Patients were seen in the office 7 to 10 days after dis-
charge from the hospital. The follow-up protocol included
physical examination of the limb with pulse status, ankle
pressures, and waveforms and graft duplex evaluation at 3
months, at 6 months, and then annually.
RESULTS
Eighty PTFE/DVP grafts were performed in 79
patients with follow-up ranging from 30 days to 4 years.
Fig 1. Intraoperative photograph showing PTFE/DVP distal
anastomosis to a posterior tibial artery.
Fig 2. Completion arteriogram after PTFE/DVP bypass graft to
a posterior tibial artery.
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Patient demographics included 39 men and 40 women
(mean age, 67 years). Risk factor analysis revealed 42
(53%) patients with diabetes mellitus, 16 (20%) patients
with renal failure, and 48 (60%) patients with increased
perioperative risk cardiac risk as assessed with Eagle’s cri-
teria. Of the 16 patients with renal failure, 12 were under-
going dialysis with the remainder having a creatinine level
greater than 2.5 mg/dL. The indication for revasculariza-
tion was limb-threatening ischemia in all patients with rest
pain in 39 (49%) limbs and gangrene or non-healing ulcer-
ation present in 41 (51%). Reasons for the lack of ade-
quate saphenous vein included previous failed lower
extremity bypass graft performed at another medical insti-
tution in 47 (59%) patients, previous coronary bypass graft
in 21 (26%), unsuitable vein quality due to size or throm-
bosis in 8 (10%), and absence of vein due to varicose vein
stripping in 4 (5%).
Bypass grafts originated from the common femoral
artery in 40 (50%) cases, the external iliac artery in 34
(43%) cases, and the superficial femoral artery in 6 (8%)
cases. Recipient arteries included the peroneal artery in 35
(44%) cases, the posterior tibial artery in 28 (35%) cases,
and the anterior tibial artery in 17 (21%) cases. Two of the
posterior tibial bypass grafts went in the inframalleolar
plantar branches.
Graft patency and limb salvage rates were determined
at follow-up intervals ranging from 6 to 48 months (Fig
3). Data were analyzed with the life-table method and
reported as patency and limb salvage ± SE.10 Primary graft
patency was 90.6% ± 3.2% at 6 months and 82.44% ±
4.42%, 77.82% ± 5.46%, 69.88% ± 7.82%, and 62.89% ±
10.6% at 12-month intervals, to 48 months. Limb salvage
was 93.3% ± 2.7% at 6 months, and 88.3% ± 3.8%, 83.3%
± 4.86%, 79.21% ± 6.77%, and 79.21% ± 8.45% at 12-
month intervals to 48 months. Of note, limb salvage and
secondary patency were equivalent at all time intervals.
Therefore, secondary patency at 4 years’ follow-up was
79.21% ± 8.45%. Beyond 48 months, six grafts remained
at risk. Three grafts failed, resulting in three amputations.
Because only six grafts remained at risk, the failures and
the amputations were not included in the life-table analy-
sis, and the results were given at a maximum of 48-month
follow-up. There was one perioperative death due to
myocardial infarction (1.25%) with a 24% total mortality
rate during the 48-month follow-up period.
Seven grafts failed in the immediate perioperative
period, leading to five amputations. Four of the patients
with failed grafts had an operative thrombectomy with no
technical problem noted at the time of reoperation. Two of
the thrombectomies were successful, and these grafts are
patent at 12 and 24 months. Two thrombectomies were
unsuccessful, resulting in amputation. Three patients went
directly to amputation without an attempt to reestablish
graft patency. A total of 17 grafts failed in the follow-up
period of 48 months, leading to 11 amputations. Two of
these failed grafts were opened by means of lytic therapy
with no anatomic abnormality noted, and one remains
patent 12 months later. Five failed grafts required a
thrombectomy, and three required revision. These three
grafts were revised with a short distal extension by the use
of a new segment of PTFE and new vein patch to bypass
progressive distal arterial disease. Two of these grafts
remain patent at 6 and 12 months. Another failed graft was
converted to an ilioprofunda bypass graft to a diseased but
patent profunda femoris artery. This bypass graft remained
functional for an additional 12 months. Distal anastomotic
anatomy of the failed grafts included 10 peroneal bypass
grafts, 9 anterior tibial bypass grafts (2 dorsalis pedis), and
5 posterior tibial bypass grafts. There were three graft
infections. Two were noted at the time graft thrombosis
Fig 3. Primary patency and limb salvage rates. Numbers on graph represent grafts at risk at beginning of specific time interval.
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 2 Neville, Tempesta, and Sidawy 269
was diagnosed, resulting in graft excision and amputation.
The remaining infection occurred in a known thrombosed
graft, leading to amputation.
DISCUSSION
Autogenous saphenous vein is the conduit of choice
for tibial revascularization. Despite the use of duplex ultra-
sound techniques to improve the ability to locate accept-
able saphenous vein, there is a seemingly growing subset
of patients in whom the choice of conduit remains prob-
lematic because of a lack of suitable saphenous vein. This
group has been estimated at almost 30% of those needing
distal reconstruction with an increase to near 50% for
those undergoing a repeat or secondary procedure.11
PTFE bypass grafts with direct anastomosis to the dis-
tal arteries have been used with generally poor results.
Clinical series report 1-year patency rates between 20% and
50% with 3-year patency rates from 12% to 40%.1,12,13
These bypass grafts are technically demanding, requiring
an anastomosis between a small, diseased tibial artery and
a fairly noncompliant prosthetic material. The major cause
of these graft failures involving PTFE bypass grafts to
infrainguinal arteries appears to be myointimal hyperplasia
at the outflow anastomosis. Smooth muscle cell migration
and proliferation result in hyperplasia distal to the toe and
at the heel of the anastomosis causing a reduction in lumen
area and subsequent graft failure.14 Thrombogenicity may
also play a role at the interface between the high resistance
outflow artery and larger prosthetic graft.15
There have been many attempts to improve the results
of PTFE bypass grafts to infrapopliteal arteries through the
interposition of venous tissue between the PTFE and recip-
ient artery. Although Siegman16 first advocated the use of
a venous cuff in 1979 to facilitate the technical perfor-
mance of anastomoses to calcified arteries, Miller et al6 first
described a vein cuff in an attempt to improve the patency
of PTFE bypass grafst to distal arteries. Miller et al
reported a benefit for the vein cuff for PTFE bypass grafts
to the below-knee popliteal artery (57% patency vs 29%
patency at 36 months) without an advantage at the above-
knee position.6 No tibial artery bypass grafts were reported
in this series. Taylor et al8 reported a technique with a vein
patch at the distal portion of the anastomosis with patency
rates of 74% and 58% at 12 and 36 months, respectively.
Stonebridge et al17 have reported a prospective, random-
ized trial for PTFE grafts with a vein cuff. They did report
a benefit for the vein cuff technique in tibial bypass grafts
(52% vs 29% at 24 months); however, the report random-
ized 246 popliteal bypass grafts and only 15 tibial grafts.
Hobson et al recently reported a benefit for tibial bypass
graft with the Miller cuff. In 30 grafts they noted 54%
patency for the cuffed grafts versus 12% patency for the
noncuffed grafts at 24 months.18 Several authors have
reported on the use of arteriovenous fistulas to improve
PTFE patency to infrainguinal arteries. Dardik et al19 use
human umbilical vein graft with a concomitant anasto-
motic arteriovenous fistula, reporting 61% patency at 36
months. Ascer et al20 have also reported on an arteriove-
nous fistula technique using the corresponding tibial vein
with a PTFE bypass graft to the vein as a type of vein cuff.
This technique has resulted in 62% patency at 36 months.
The Albany group has recently reported a retrospective
series comparing PTFE grafts with the Tyrrell/Wolfe vein
boot technique with grafts performed with an arteriove-
nous fistula distal to the actual anastomosis.21 This St
Mary’s boot technique has been advocated as taking
advantage of the best features of the prior techniques with
promising early clinical results. The Albany series involved
predominantly tibial bypass grafts, but did include a num-
ber of popliteal grafts. They noted similar graft patency
between the two techniques at 12 and 36 months (96% vs
86% and 38% vs 48%, respectively). These authors indicated
that they prefer the St Mary’s boot technique because of
technical ease and advantages in terms of graft salvage and
secondary patency.
The addition of a Miller cuff, Taylor patch, or St
Mary’s boot to PTFE bypass grafts has led to a seeming
improvement in patency versus PTFE alone; however,
these adjunctive techniques have some theoretical and
practical disadvantages. Miller6 reported several early graft
thromboses possibly related to increased turbulence
caused by excessive bulging of the venous tissue at the dis-
tal anastomosis. The Taylor patch involves the direct
suturing of PTFE to the artery at the heel of the anasto-
mosis where hyperplasia is known to develop and requires
the dissection of a long segment of tibial artery to accom-
modate the anastomosis. Our technique involved a stan-
dard patch angioplasty already familiar to vascular
surgeons, with subsequent implantation of a PTFE graft
into the vein patch. The length of vein segment required
for this technique is minimized (2-4 cm). The vein is min-
imally trimmed to allow a pseudocuff to form without
excessive bulging. The PTFE graft must be anastomosed
to the proximal two thirds of the vein patch. This leaves a
rim of venous tissue at the heel of the anastomosis and
allows a vein pseudocuff to develop at the distal portion of
the anastomosis. Ideally, the distal portion of the vein
patch expands in a cuff-like configuration under arterial
flow without ballooning into a protuberant bulge.
Completion arteriography is mandatory in these cases
because even a minor error can lead to graft failure.
The advantages bestowed by venous tissue at the distal
anastomosis derive from both biologic and mechanical fac-
tors. A biologic “buffer zone” between the tibial artery and
prosthetic graft has appealing theoretical possibilities.
Although the causes of myointimal hyperplasia have not
been completely delineated, the addition of venous tissue to
PTFE grafts at the distal anastomosis may lead to a favor-
able biologic situation and decrease the development of
hyperplasia as has been demonstrated in an animal model.22
Venous endothelium may also confer a beneficial effect
through fibrinolytic and antiplatelet activity, although these
effects remain unproved. The mechanical factors of shear
stress and compliance mismatch have also been implicated
in prosthetic graft failure. Theoretically, vein interposed
between a stiff prosthetic graft and a more pliable artery
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would minimize the expansibility mismatch created with
pulsatile flow and thus decrease mechanical injury at the
anastomosis. However, an animal study addressing these
mechanical properties did not prove them important in the
reduction of observed hyperplasia.23 Anastomotic turbu-
lence and outflow resistance have also been suggested as
mechanisms of graft failure. Anastomotic geometry may be
altered by the presence of vein at the distal anastomosis,
thereby effecting turbulence and shear forces that play a
role in the hyperplastic process.15,24 Finally, it is possible
that venous tissue simply enlarges the distal anastomosis so
that the formation of hyperplasia must encroach on a wider
lumen before becoming clinically significant. The venous
tissue is also technically easier to suture to small, calcified
tibial arteries as originally observed by Seigman.16 The sec-
ondary suture line between the PTFE graft and vein also
becomes more technically appealing.
The current series involves only tibial artery bypass
graft for patients in a limb-threatening situation. The
patient group was typically high risk with comorbidities of
diabetes, renal failure, and coronary artery disease. Careful
perioperative medical care and excellent anesthetic tech-
niques are crucial for acceptable results. We noted a rela-
tively high proportion of women and renal failure in this
series, possibly given the tertiary nature of the referral pat-
terns. Most patients (59%) were referred for evaluation
after one or more previous attempts at bypass grafting had
failed. This led to a relatively high number of grafts origi-
nating from the external iliac artery to avoid a scarred or
hostile groin. This was possible because graft length was
not an issue given the use of PTFE. We also noted that
graft failures could be lysed or thrombectomized often
without any underlying anatomic defect found as the
cause of graft failure. This was also noted by the Albany
group in their failed grafts. Therefore, we think that an
attempt at lytic therapy or thrombectomy through a lim-
ited distal incision is warranted in the event of graft failure.
Intraoperative arteriography can then be used to deter-
mine the need for anastomotic revision or extension with
a new vein cuff. However, we do note that one graft in the
series failed because of progression of proximal disease in
the common and external iliac arteries.
In conclusion, we think that patients in danger of limb
loss without adequate saphenous vein can be considered
for tibial bypass graft with PTFE/DVP as the conduit.
This series shows that acceptable long-term patency and
limb salvage can be achieved in these challenging patients.
As the population ages and policies toward limb salvage
become more aggressive, vascular surgeons will require
alternative conduits to autogenous saphenous vein in a
certain subset of patients. Although this was not a ran-
domized trial, these early results indicate that a PTFE graft
with a DVP may prove an acceptable alternative in the
absence of saphenous vein. In our practice PTFE/DVP is
preferred to PTFE bypass graft alone or composite grafts
constructed with PTFE and longer segments of saphenous
vein. A multicenter prospective randomized trial may be of
benefit to address the question of the best alternative for
the patient without suitable autogenous saphenous vein
for limb salvage. Until then, we will offer the patient with-
out adequate vein PTFE bypass grafts to tibial arteries for
limb salvage with the addition of a DVP.
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We did use arm vein, actually a number of times, in our tib-
ial artery series, for which I reported the numbers. We got away
from the arm vein for a couple reasons. One was we can do the
vein patch procedure all under epidural anesthesia, which in our
anesthesiologist’s opinion is better than general anesthesia for
some of the people we were working on, although I know that’s
also debatable. We also did, on occasion, have trouble getting
enough length with an arm vein, when we thought we had to go
from the external iliac artery down to a distal tibial artery. So the
combination of a length problem with trying to do these under
epidural anesthesia, since that is the strong preference of our anes-
thesia team, led us to this particular technique.
Finally, in terms of your diabetic question, that’s a very
good question. We did not have as many SFAs and popliteal
bypasses as you might have imagined. Although I think in those
shorter bypasses we often could find enough autologous vein,
whether it be arm vein or splicing together a couple of seg-
ments of saphenous vein, we would use vein if we were going
with a shorter bypass.
Dr Frank J. Veith (Bronx, NY). I enjoyed this paper, since I
was the first one in 1978 to advocate tibial bypasses with PTFE.
It’s nice to know that there still appears to be a role for them.
In my heart, I remain unconvinced that the patches, the boots,
the cuffs make a difference. Four years ago Richard Parsons from
our group presented our data at this meeting with cases very similar
to yours, all followed for 4 or 5 years or until they died (J Vasc Surg
1996;23:347). The secondary patency rates at 3 and 5 years were
55% and 43%, respectively. And the limb salvage rates at 3 and 5
years were 71% and 66%, respectively. These are not quite as good
as yours, but probably not statistically significantly different. So we
still do the procedure without the cuffs and boots, but occasionally
we do use a patch when we have a particularly small or calcified
artery. It’s a lot easier to do, and it makes the procedure technically
better. However, I believe that until we have an even larger ran-
domized study than the British study (which had abysmal results
with the PTFE grafts without the cuffs or boots), I still remain
unconvinced. I also remain unconvinced about the benefits of AV
fistulas and all the other adjuncts that have been advocated because
of our results summarized in the Parsons article. I enjoyed this paper
and commend you for telling us about a technically easier adjunct
that may help to improve the patency of infrapopliteal PTFE grafts.
They remain a useful procedure in our limb salvage practice.
Dr Neville. Thank you very much, Dr Veith. And from the
data this paper represents, I can’t begin to convince you of our
separate biases; but I do agree wholeheartedly that this technique,
I think, in most people’s hands, makes it technically easier to per-
form bypasses to these small calcified tibial arteries instead of
sewing the PTFE directly to the artery.
Dr Michael F. Silane (New York, NY). We also are of the bias
that these vein patches are a major advantage over the PTFE by
themselves. We have been doing them for about 11 years now.
And I think this is at least the third study to support this. There
was, of course, the Taylor study, and then there was the study from
New Jersey, and now this study. I think Dr Kemplinski was getting
ready to do a randomized study between synthetic with vein patch
and veins pieced together in a composite fashion. I think we’re all
still in a quandary. I don’t think anybody questions that a good
saphenous vein is our first choice. But the quandary is if we don’t
have a saphenous vein that reaches from the groin to the ankle,
what’s the second best choice? And I think it’s time for a random-
ized study comparing PTFE and a patch, to composite veins, to
Dr John H. N. Wolfe (London, United Kingdom). Thank
you very much for sending me a very clear manuscript well before
the meeting. Since, being British, I’ve been relegated to the oats
that have gone through the horse by John Porter, you might like
to take my comments with a pinch of salt.
I think that the thing we must first of all recognize is that
these are excellent results. But we cannot be sure at this stage
whether these excellent results are due to the skill of the surgeon
or to a new technique. That is something that remains to be seen.
We also have to be aware that, like all series, there is a mix-
ture of what I would call subcritical ischemia and critical ischemia.
In the truly critically ischemic group, the patients with tissue loss,
95% of people lose their limbs at 6 months or a year without inter-
vention. On the other hand, in those patients with rest pain alone
(on a meta-analysis that has been done), 30% might keep their
limb even without intervention. So that has to be taken into
account when looking at results.
I believe that these vein interpositions help technically, and
that is well supported by Mark Tyrrell’s experimental work on the
relationship between the vein interposition and direct PTFE anas-
tomosis directly onto an artery, and also the Joint Vascular
Research Group (JVRG) data on the randomized trial, which
showed that it was the technical advantage of the collar that
improved results. What I am less sure about is whether that advan-
tage is maintained over a period of time and your follow-up is rel-
atively short. My question to you is whether you are in a position
to say that there is an advantage for this technique over PTFE
alone and whether it does, in fact, do as well as autologous vein.
I do not personally believe that the choice of the interposition
vein between the PTFE and the artery is of great consequence,
providing it provides a short venous tunnel into the artery.
Another question I think that we have to answer is why you
did not use arm vein. In my practice and, I think, in most tertiary
referral practices, approximately 25% of grafts will be either spliced
vein or arm vein. And in your series it appeared to be either long
saphenous, as a full-length vein, or your new technique. Therefore,
you clearly believe that this technique is as good as spliced vein.
And finally, 50% of your patients were diabetic. One of the
advantages of diabetic patients is that the graft can often be
started well down the leg, sometimes even as low as the popliteal
fossa. Despite the fact that you have acquired a big diabetic pop-
ulation, your grafts were full length, with only 8% from the super-
ficial femoral artery. Maybe, if you had been able to use shorter
grafts, you would have been able to use vein, not PTFE.
Thank you.
Dr Richard F. Neville. Thank you very much, Mr Wolfe. As a
recognized expert in this field, I appreciate your comments.
In terms of our limb salvage, I think this particular series does
represent some certain degree of patient selection. If a tibial
artery appeared to us horribly disadvantaged, at least early in the
series, we sometimes did go right to primary amputation.
Conversely, we do work very closely with a plastic surgeon whose
major interest is limb salvage and has a very elegant series of flaps
and various soft tissue procedures that I think have saved limbs
that otherwise would not have been saved.
In terms of our long-term follow-up, I would not begin to
say that this procedure is anywhere near as good as the autolo-
gous saphenous vein, and that’s not what we’re saying. I do
believe in my heart of hearts that it’s better than PTFE alone. I
can’t prove that to you, but in our experience it’s better than
purely a PTFE graft to the tibial artery.
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possibly synthetic to the tibial by itself. But I suspect the latter is
going to be out of the ballpark very quickly. I think the vein patch
or the composite veins are the second choice, but I don’t know
which is better and I think it’s time to do that study.
Dr Neville. I agree wholeheartedly.
Dr Peter J. Pappas (Newark, NJ). Rich, I rise to congratulate
you and your group and also to acknowledge your group’s lead-
ership in recommending the use of vein interposition cuffs. I’d
like to point something out though in your study that I think is
of major significance.
First of all, all of these were done to tibial vessels. Your 80
patients constitute the largest series, at least to my knowledge, of
PTFE with vein cuffs to a tibial vessel. The thing that struck me,
though, in your presentation was that all of your patients were on
Coumadin. And to my knowledge, that’s the first study using the
vein interposition cuff in conjunction with Coumadin. I think this
fact is reflective of your date. Most of the long-term studies have
reported that at 2 years there seems to be a 60% patency, and
thereafter, the patency seems to drop. In your study the patency
seems to have been maintained. And I’m beginning to wonder if
that’s not a reflection of the anticoagulation in addition to the
vein cuff. However, I was wondering if you noticed any difference
with your bypasses that went to the peroneal? In our series we had
the same experience where most of the graft failures were to the
peroneal. And although we couldn’t show a statistical difference
between peroneal arteries versus any other arteries, there seemed
to be a trend toward the peroneals failing more. I was wondering
if you also noticed that in your series as well?
Dr Neville. Those are two great points, Peter. We are very
aggressive with anticoagulation. Our nurse practitioner, who is
listed as the second author, aggressively follows these people in
terms of their Coumadin, managing their Coumadin, making
sure the INR is around 2.0. She’ll bring them in and counsel
them on how to take their Coumadin. We are very aggressive, and
she’s great at keeping those Coumadin levels where they need to
be. We also do use antiplatelet therapy as well.
In terms of the peroneal arteries, we looked at that. And of
the grafts that failed, there were not a disproportionate number
of peroneals. It was approximately equally distributed between
posterior tibial, anterior tibial, and peroneal bypasses. There really
didn’t seem to be much difference at all.
And also back to the Coumadin, anecdotally, of the grafts
that failed, we did notice a couple of patients who had their
Coumadin stopped for dental procedures or another operative
procedure, and the graft failed. There weren’t enough to come up
with any statistical evaluation, but we did anecdotally note that
several of the failed grafts, when we brought them back to
thrombectomize them, had no anatomic problem.
Dr Sateesh C. Babu (Valhalla, NY). I have a question about
the placement of the graft. Is it subcutaneous? And your peroneal
approach, is it lateral or medial?
Dr Neville. Very good questions. It’s a subcutaneous
approach. We do occasionally tunnel it anatomically, whichever
way it lies the best, but usually subcutaneously. For the majority
of our approaches, the proximal two thirds of the peroneal, we
approach medially. The distal one third we approach laterally.
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